Skip to main content
. Author manuscript; available in PMC: 2010 Mar 10.
Published in final edited form as: Circulation. 2009 Feb 23;119(9):1211–1219. doi: 10.1161/CIRCULATIONAHA.108.814947

Table 2. Treatment Practices in Patients Hospitalized With Acute Myocardial Infarction According to the Presence of Cardiogenic Shock.

Total Sample Patients Hospitalized in 2001, 2003, and 2005


Shock
Present (+)
(n=905)
Shock
Absent (-)
(n=12,758)
p Value Shock
Present (+)
(n=173)
Shock
Absent (-)
(n=3,126)
p Value
Medications (%)
 Angiotensin converting enzyme inhibitors/angiotensin receptor blockers**** 48.6 47.9 0.74 62.4 68.1 0.13
 Aspirin 52.2 65.7 <.001 90.2 91.4 0.60
 Beta blockers 40.2 63.4 <.001 76.9 90.2 <0.001
 Calcium channel blockers** 26.0 38.2 <.001 20.2 25.4 0.12
 Lipid lowering agents*** 20.2 31.0 <.001 56.7 66.8 <0.01
 Thrombolytics*** 18.8 15.9 0.05 6.4 5.3 0.55
Procedures (%)
 Cardiac catheterization 35.8 30.7 <.001 74.0 55.5 <0.001
 Coronary artery bypass graft surgery* 6.9 3.8 <.001 7.5 6.0 0.44
 Percutaneous coronary intervention*** 28.8 19.3 <.001 57.8 38.6 <0.001
 Intraortic balloon counterpulsation 29.7 2.0 <.001 54.3 3.5 <0.001
*

81-05 only

**

84-05 only

***

86-05 only

****

90-05 only